Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer.
about
Progress in the clinical detection of heterogeneity in breast cancerQuantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer.In situ imaging of quantum dot-AZD4547 conjugates for tracking the dynamic behavior of fibroblast growth factor receptor 3.Characterization of the Tumor Microenvironment and Tumor-Stroma Interaction by Non-invasive Preclinical Imaging
P2860
Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Quantum dot-based in situ simu ...... triple-negative breast cancer.
@en
Quantum dot-based in situ simu ...... triple-negative breast cancer.
@nl
type
label
Quantum dot-based in situ simu ...... triple-negative breast cancer.
@en
Quantum dot-based in situ simu ...... triple-negative breast cancer.
@nl
prefLabel
Quantum dot-based in situ simu ...... triple-negative breast cancer.
@en
Quantum dot-based in situ simu ...... triple-negative breast cancer.
@nl
P2093
P2860
P1433
P1476
Quantum dot-based in situ simu ...... triple-negative breast cancer.
@en
P2093
Chuang Chen
Hong-Mei Zheng
Jin-Zhong Sun
Ming-Wei Wang
Sheng-Rong Sun
Xin-Hong Wu
P2860
P2888
P304
P356
10.1007/S13277-015-4079-6
P577
2015-09-19T00:00:00Z